共 50 条
- [31] Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial (vol 8, pg 963, 2020) LANCET RESPIRATORY MEDICINE, 2021, 9 (03): : E29 - E29
- [32] Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : 963 - 974
- [33] Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial LANCET HAEMATOLOGY, 2017, 4 (11): : E534 - E543
- [35] Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : 1141 - 1153
- [36] Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial LANCET, 2012, 380 (9853): : 1583 - 1589
- [39] Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial LANCET, 2008, 371 (9631): : 2192 - 2200
- [40] Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial LANCET, 2021, 397 (10268): : 51 - 60